+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Leukocyte Antigens Typing Market - Global Forecast 2026-2032- Product Image
Human Leukocyte Antigens Typing Market - Global Forecast 2026-2032- Product Image
Sale

Human Leukocyte Antigens Typing Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6160594
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Human Leukocyte Antigens Typing Market is projected to reach USD 1.59 Billion in 2026. It is expected to continue growing at a CAGR of 5.85%, reaching USD 2.25 Billion by 2032.

Human Leukocyte Antigens Typing: Executive Overview

Human leukocyte antigens (HLA) typing identifies genetic markers that regulate immune recognition and is central to transplant compatibility assessment, donor selection, transfusion support, disease association studies, and pharmacogenomic risk evaluation. The field combines molecular diagnostics, immunogenetics, bioinformatics, and clinical decision support. Its relevance is increasing as transplant programs expand, precision medicine becomes more integrated into care pathways, and laboratories adopt higher-resolution testing methods.

Resolution, Standardization, and Workflow Integration Are Reshaping HLA Typing

The landscape is shifting from serological and low-resolution approaches toward sequence-based, high-resolution typing that can distinguish clinically relevant alleles more precisely. Long-read and targeted sequencing workflows are helping laboratories resolve complex genotypes, while automated extraction, library preparation, and interpretation tools are improving throughput and reproducibility. At the same time, laboratories face continuing requirements for proficiency testing, reference nomenclature, quality assurance, data interoperability, and appropriate handling of donor and patient genetic information.

Artificial Intelligence Is Strengthening Interpretation, Prioritization, and Quality Control

Artificial intelligence can support HLA typing by identifying sequence patterns, flagging ambiguous calls, prioritizing clinically relevant donor-recipient mismatches, and detecting anomalies in laboratory quality data. Machine-learning models may also assist research into HLA-disease associations and immune-response prediction. However, dependable clinical use requires representative validation datasets, transparent performance metrics, human oversight, cybersecurity controls, and careful management of population bias. AI is therefore best positioned as an interpretive and workflow-support layer rather than a substitute for validated laboratory procedures or specialist judgment.

Regional Insights: Capacity and Access Remain Uneven Across Six Geographies

North America benefits from mature transplant infrastructure, advanced molecular laboratories, and established donor registries, while regulatory and reimbursement requirements shape implementation. Europe combines strong immunogenetics expertise with cross-border coordination, but differences in national systems and data governance can complicate harmonization. Asia-Pacific is characterized by expanding transplant services, substantial population diversity, and growing sequencing capacity, alongside uneven access between urban and rural settings. Latin America continues to develop laboratory networks and donor registries, with access and funding varying considerably by country. The Middle East is strengthening specialized clinical services and regional collaboration, while consanguinity and population-specific allele patterns heighten the value of locally representative reference data. Africa has important unmet needs in transplant compatibility infrastructure and genomic representation, creating priorities around workforce development, registry expansion, and affordable testing access.

Group Insights: Alliances and Economic Blocs Shape Collaboration

ASEAN members are positioned to benefit from shared laboratory standards, regional donor coordination, and workforce exchange, although health-system capabilities differ widely. BRICS countries bring substantial population diversity and research capacity, making collaboration on reference datasets, transplantation, and locally relevant interpretation particularly important. The European Union emphasizes cross-border healthcare coordination, data protection, and laboratory harmonization. G7 members generally have advanced sequencing and transplant ecosystems, with attention focused on clinical validation, interoperability, and equitable access. GCC countries are investing in specialized healthcare and genomic infrastructure, while regional compatibility and data-sharing frameworks remain important. NATO members span diverse health systems, but cooperation in biomedical readiness, laboratory resilience, and secure data infrastructure can support broader immunogenetics capabilities.

Country Insights: National Priorities Reflect Distinct Clinical and Genomic Contexts

Australia combines established transplant services with a strong need to represent its diverse population and geographically dispersed communities. Brazil is expanding genomic and transplant capabilities while addressing regional disparities in laboratory access. Canada’s distributed healthcare structure makes interoperability, donor coordination, and Indigenous population representation important considerations. China is advancing sequencing, clinical genomics, and transplant infrastructure at scale, with continued attention to standardization and data governance. France, Germany, Italy, and Spain benefit from sophisticated clinical laboratory networks, while national implementation differences influence procurement, reimbursement, and data exchange. India’s large and diverse population creates major opportunities for locally representative HLA reference resources and broader access to molecular testing. Japan and South Korea have advanced healthcare and research systems, with priorities including high-resolution typing, aging-population care, and integration with precision medicine. Mexico is developing transplant and laboratory capacity while addressing geographic access. Russia’s capabilities and research priorities are shaped by national infrastructure, population diversity, and data-policy considerations. The United Kingdom maintains strong immunogenetics expertise and registry coordination, with continued emphasis on quality, interoperability, and equitable donor representation. The United States combines extensive transplant, registry, and sequencing infrastructure, while focusing on clinical evidence, reimbursement, privacy, and improved representation of underrepresented populations.

Action Priorities for Leaders: Build Interoperable, Representative, and Clinically Validated Workflows

Industry leaders should prioritize high-resolution methods that are validated for the intended clinical use, supported by robust controls and clear interpretation rules. Investments should focus on interoperable laboratory information systems, standardized nomenclature, secure data exchange, and automation that reduces avoidable manual variation. Organizations should also expand reference datasets and donor recruitment among populations that remain underrepresented, while establishing transparent governance for genetic data. AI initiatives should begin with narrowly defined, measurable use cases and prospective validation. Finally, partnerships among transplant centers, registries, laboratories, regulators, and public-health institutions can improve workforce capability, evidence generation, and equitable access to testing.

Research Methodology: Evidence-Led Synthesis of HLA Typing Developments

This executive summary uses a structured synthesis of established clinical, laboratory, regulatory, and scientific themes relevant to HLA typing. The assessment considers technological evolution, workflow integration, AI applications, regional health-system conditions, population diversity, transplant infrastructure, and data-governance requirements. Findings are framed qualitatively and exclude market estimates, market sizing, market shares, forecasts, and company-specific claims. Regional, group, and country perspectives are integrated to distinguish broadly applicable developments from context-dependent implementation priorities.

Conclusion: Precision, Representation, and Governance Define the Next Phase

HLA typing is moving toward more precise, sequence-based characterization integrated with automated laboratory workflows and clinically oriented interpretation. The most important strategic challenges are not technological alone: they include representation of diverse populations, consistency across laboratories, secure data stewardship, workforce readiness, and evidence-based adoption of AI. Organizations that combine validated high-resolution testing with interoperable systems, inclusive reference data, and strong clinical governance will be better positioned to support transplantation and broader immunogenetics applications responsibly.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Human Leukocyte Antigens Typing Market, by Product Type
7.1. Introduction
7.2. Instruments
7.2.1. Flow Cytometers
7.2.2. PCR Systems
7.2.3. Sequencing Instruments
7.2.3.1. Next-Generation Sequencers
7.2.3.2. Sanger Sequencers
7.3. Reagents & Consumables
7.3.1. Assay Consumables
7.3.2. NGS & Sanger Sequencing Kits / Library Prep Kits
7.3.3. PCR Reagents
7.4. Software & Services
8. Human Leukocyte Antigens Typing Market, by Application
8.1. Introduction
8.2. Disease Association Studies
8.3. Forensic Studies
8.4. Pharmacogenomics
8.5. Transplantation
9. Human Leukocyte Antigens Typing Market, by End User
9.1. Introduction
9.2. Hospitals & Diagnostic Labs
9.3. Research & Academic Institutes
9.4. Transplant Centers
10. Human Leukocyte Antigens Typing Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Human Leukocyte Antigens Typing Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Human Leukocyte Antigens Typing Market, by Country
12.1. Introduction
12.2. United States
12.3. Germany
12.4. China
12.5. United Kingdom
12.6. India
12.7. Japan
12.8. Russia
12.9. Brazil
12.10. Canada
12.11. Italy
12.12. Mexico
12.13. France
12.14. Spain
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Abbott Laboratories
14.2. Agilent Technologies, Inc.
14.3. BAG Diagnostics GmbH
14.4. Beckman Coulter Life Sciences
14.5. Becton, Dickinson and Company (BD)
14.6. Bio-Rad Laboratories, Inc.
14.7. Biofortuna Ltd.
14.8. Bruker Corporation
14.9. CareDx, Inc.
14.10. Creative Biolabs
14.11. Eurofins Scientific
14.12. F. Hoffmann-La Roche Ltd.
14.13. Fujirebio, Inc.
14.14. HistoGenetics LLC
14.15. Hologic, Inc.
14.16. Illumina, Inc.
14.17. Immucor, Inc.
14.18. Omixon Inc.
14.19. Oxford Nanopore Technologies Plc
14.20. Pacific Biosciences (PacBio)
14.21. QIAGEN N.V.
14.22. Takara Bio, Inc.
14.23. TBG Diagnostics Ltd.
14.24. Thermo Fisher Scientific Inc.
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Human Leukocyte Antigens Typing Market, Years Considered for the Study
FIGURE 2. Global Human Leukocyte Antigens Typing Market, Research Design
FIGURE 3. Global Human Leukocyte Antigens Typing Market, Research Framework
FIGURE 4. Global Human Leukocyte Antigens Typing Market, Data Triangulation
FIGURE 5. Global Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Human Leukocyte Antigens Typing Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Human Leukocyte Antigens Typing Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Human Leukocyte Antigens Typing Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Human Leukocyte Antigens Typing Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Human Leukocyte Antigens Typing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Human Leukocyte Antigens Typing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Human Leukocyte Antigens Typing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Human Leukocyte Antigens Typing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Human Leukocyte Antigens Typing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Human Leukocyte Antigens Typing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Human Leukocyte Antigens Typing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Human Leukocyte Antigens Typing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Human Leukocyte Antigens Typing Market Segmentation & Coverage
TABLE 2. Global Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Flow Cytometers Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Flow Cytometers Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Flow Cytometers Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global PCR Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global PCR Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global PCR Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Sequencing Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Sequencing Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Sequencing Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Next-Generation Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Next-Generation Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Next-Generation Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Sanger Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Sanger Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Sanger Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Reagents & Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Reagents & Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Reagents & Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Assay Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Assay Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Assay Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global NGS & Sanger Sequencing Kits / Library Prep Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global NGS & Sanger Sequencing Kits / Library Prep Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global NGS & Sanger Sequencing Kits / Library Prep Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global PCR Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global PCR Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global PCR Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Software & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Software & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Software & Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 38. Global Disease Association Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Disease Association Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Disease Association Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Forensic Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Forensic Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Forensic Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Pharmacogenomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Pharmacogenomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Pharmacogenomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Transplantation Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Transplantation Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Transplantation Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 51. Global Hospitals & Diagnostic Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Hospitals & Diagnostic Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Hospitals & Diagnostic Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Research & Academic Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Research & Academic Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Research & Academic Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Transplant Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Transplant Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Transplant Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Human Leukocyte Antigens Typing Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Human Leukocyte Antigens Typing Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. North America Human Leukocyte Antigens Typing Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. North America Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 70. North America Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 71. North America Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 72. North America Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 73. North America Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 74. North America Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 75. Latin America Human Leukocyte Antigens Typing Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Latin America Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 77. Latin America Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 78. Latin America Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 79. Latin America Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 80. Latin America Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. Latin America Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Europe Human Leukocyte Antigens Typing Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Europe Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 84. Europe Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 85. Europe Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 86. Europe Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 87. Europe Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. Europe Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. Middle East Human Leukocyte Antigens Typing Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Middle East Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 91. Middle East Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 92. Middle East Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 93. Middle East Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 94. Middle East Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. Middle East Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Africa Human Leukocyte Antigens Typing Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Africa Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 98. Africa Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 99. Africa Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 100. Africa Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 101. Africa Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. Africa Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. Global Human Leukocyte Antigens Typing Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. ASEAN Human Leukocyte Antigens Typing Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. ASEAN Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 106. ASEAN Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 107. ASEAN Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 108. ASEAN Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 109. ASEAN Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. ASEAN Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. GCC Human Leukocyte Antigens Typing Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. GCC Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. GCC Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 114. GCC Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 115. GCC Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 116. GCC Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. GCC Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. European Union Human Leukocyte Antigens Typing Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. European Union Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 120. European Union Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 121. European Union Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 122. European Union Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 123. European Union Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 124. European Union Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. BRICS Human Leukocyte Antigens Typing Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. BRICS Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. BRICS Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 128. BRICS Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 129. BRICS Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 130. BRICS Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. BRICS Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. G7 Human Leukocyte Antigens Typing Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. G7 Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 134. G7 Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 135. G7 Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 136. G7 Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 137. G7 Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. G7 Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. NATO Human Leukocyte Antigens Typing Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. NATO Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. NATO Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 142. NATO Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 143. NATO Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 144. NATO Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. NATO Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. Global Human Leukocyte Antigens Typing Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. United States Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 148. United States Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. United States Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 150. United States Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 151. United States Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 152. United States Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. United States Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Germany Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 155. Germany Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 156. Germany Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 157. Germany Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 158. Germany Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 159. Germany Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. Germany Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. China Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 162. China Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. China Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 164. China Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 165. China Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 166. China Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 167. China Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. United Kingdom Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 169. United Kingdom Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 170. United Kingdom Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 171. United Kingdom Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 172. United Kingdom Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 173. United Kingdom Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. United Kingdom Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. India Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 176. India Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. India Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 178. India Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 179. India Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 180. India Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. India Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Japan Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 183. Japan Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. Japan Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 185. Japan Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 186. Japan Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 187. Japan Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. Japan Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Russia Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 190. Russia Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. Russia Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 192. Russia Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 193. Russia Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 194. Russia Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. Russia Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Brazil Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 197. Brazil Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. Brazil Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 199. Brazil Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 200. Brazil Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 201. Brazil Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. Brazil Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Canada Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 204. Canada Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. Canada Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 206. Canada Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 207. Canada Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 208. Canada Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. Canada Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. Italy Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 211. Italy Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. Italy Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 213. Italy Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 214. Italy Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 215. Italy Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. Italy Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. Mexico Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 218. Mexico Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. Mexico Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 220. Mexico Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 221. Mexico Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 222. Mexico Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 223. Mexico Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. France Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 225. France Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. France Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 227. France Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 228. France Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 229. France Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. France Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Spain Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 232. Spain Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 233. Spain Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 234. Spain Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 235. Spain Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 236. Spain Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 237. Spain Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. Australia Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 239. Australia Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. Australia Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 241. Australia Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 242. Australia Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 243. Australia Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. Australia Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. South Korea Human Leukocyte Antigens Typing Market Size, 2017-2032 (USD Million)
TABLE 246. South Korea Human Leukocyte Antigens Typing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 247. South Korea Human Leukocyte Antigens Typing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 248. South Korea Human Leukocyte Antigens Typing Market Size, by Sequencing Instruments, 2017-2032 (USD Million)
TABLE 249. South Korea Human Leukocyte Antigens Typing Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 250. South Korea Human Leukocyte Antigens Typing Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. South Korea Human Leukocyte Antigens Typing Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. Global Human Leukocyte Antigens Typing Market Share, by Key Player, 2025
TABLE 253. Global Human Leukocyte Antigens Typing Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • BAG Diagnostics GmbH
  • Beckman Coulter Life Sciences
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • Biofortuna Ltd.
  • Bruker Corporation
  • CareDx, Inc.
  • Creative Biolabs
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Fujirebio, Inc.
  • HistoGenetics LLC
  • Hologic, Inc.
  • Illumina, Inc.
  • Immucor, Inc.
  • Omixon Inc.
  • Oxford Nanopore Technologies Plc
  • Pacific Biosciences (PacBio)
  • QIAGEN N.V.
  • Takara Bio, Inc.
  • TBG Diagnostics Ltd.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Human Leukocyte Antigen (HLA) Typing for Oncology Immunotherapy Global Market Report 2026 - Product Image

Human Leukocyte Antigen (HLA) Typing for Oncology Immunotherapy Global Market Report 2026

  • Report
  • 250 Pages
  • Global
From
HLA Typing Kit Market - Global Forecast 2026-2032 - Product Image

HLA Typing Kit Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
HLA Typing Market - Global Forecast 2026-2032 - Product Image

HLA Typing Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
HLA Typing Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Technology, Application, End User - Product Image

HLA Typing Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Technology, Application, End User

  • Report
  • 160 Pages
  • Global
From
HLA Typing for Transplant - Global Strategic Business Report - Product Image

HLA Typing for Transplant - Global Strategic Business Report

  • Report
  • 317 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.